NRGene Technologies Ltd (TLV: NRGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA245.00
-22.00 (-8.24%)
Dec 19, 2024, 12:43 PM IDT
NRGene Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 1.56 | 2 | 3.16 | 4.46 | 7.04 | 7.61 | Upgrade
|
| Revenue Growth (YoY) | -44.86% | -36.66% | -29.22% | -36.56% | -7.52% | 4.02% | Upgrade
|
| Cost of Revenue | 0.85 | 1.1 | 1.45 | 2 | 2.52 | 2.61 | Upgrade
|
| Gross Profit | 0.7 | 0.9 | 1.71 | 2.47 | 4.51 | 5 | Upgrade
|
| Selling, General & Admin | 3.89 | 4 | 4.78 | 7.49 | 3.86 | 5.84 | Upgrade
|
| Research & Development | 1.38 | 2.18 | 2.43 | 3.53 | 2.44 | 2.45 | Upgrade
|
| Other Operating Expenses | -0.57 | -0.59 | -0.14 | -0.16 | -0.07 | - | Upgrade
|
| Operating Expenses | 4.71 | 5.59 | 7.07 | 10.87 | 6.23 | 8.29 | Upgrade
|
| Operating Income | -4 | -4.69 | -5.36 | -8.4 | -1.72 | -3.29 | Upgrade
|
| Interest Expense | - | -0.07 | -0.29 | -0.41 | -1.22 | -0.75 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.26 | 0.14 | 0.22 | - | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.13 | -0.13 | -0.52 | 0.22 | -0.11 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.19 | 0.07 | -0.05 | 0.18 | Upgrade
|
| EBT Excluding Unusual Items | -3.99 | -4.64 | -6.21 | -8.3 | -3.1 | -3.89 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.61 | -0.61 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Pretax Income | -4.58 | -5.23 | -6.21 | -8.3 | -3.1 | -3.89 | Upgrade
|
| Income Tax Expense | 0 | 0.01 | -0.01 | 0.04 | 0.05 | 0.02 | Upgrade
|
| Net Income | -4.58 | -5.24 | -6.21 | -8.34 | -3.15 | -3.91 | Upgrade
|
| Net Income to Common | -4.58 | -5.24 | -6.21 | -8.34 | -3.15 | -3.91 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 12 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 12 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | 0.36% | 0.69% | 3.20% | 37.44% | 0.37% | 1.09% | Upgrade
|
| EPS (Basic) | -0.36 | -0.42 | -0.50 | -0.69 | -0.36 | -0.45 | Upgrade
|
| EPS (Diluted) | -0.37 | -0.42 | -0.50 | -0.69 | -0.36 | -0.45 | Upgrade
|
| Free Cash Flow | -4.25 | -4.06 | -6.34 | -6.07 | -1.44 | -3.6 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.32 | -0.51 | -0.50 | -0.16 | -0.41 | Upgrade
|
| Gross Margin | 45.12% | 45.03% | 54.16% | 55.23% | 64.16% | 65.66% | Upgrade
|
| Operating Margin | -257.26% | -234.53% | -169.52% | -188.26% | -24.41% | -43.28% | Upgrade
|
| Profit Margin | -294.02% | -262.02% | -196.49% | -186.83% | -44.72% | -51.41% | Upgrade
|
| Free Cash Flow Margin | -273.20% | -202.80% | -200.54% | -136.05% | -20.53% | -47.34% | Upgrade
|
| EBITDA | -3.76 | -4.5 | -5.19 | -8.37 | -1.7 | -3.03 | Upgrade
|
| EBITDA Margin | -241.77% | -224.94% | -164.42% | -187.47% | -24.11% | -39.88% | Upgrade
|
| D&A For EBITDA | 0.24 | 0.19 | 0.16 | 0.04 | 0.02 | 0.26 | Upgrade
|
| EBIT | -4 | -4.69 | -5.36 | -8.4 | -1.72 | -3.29 | Upgrade
|
| EBIT Margin | -257.26% | -234.53% | -169.52% | -188.26% | -24.41% | -43.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.